Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 2Phase 1 2Phase NA 1Phase EARLY_PHASE1 1Phase 2/3 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Ovarian Neoplasms 28Small Cell Lung Carcinoma 24Fallopian Tube Neoplasms 12Uterine Cervical Neoplasms 8Carcinoma, Ovarian Epithelial 8Neuroblastoma 7Lung Neoplasms 6Sarcoma 3Neoplasms 3Retinoblastoma 2Neoplasm Metastasis 2Malignant mesenchymal tumor 2Ganglioneuroblastoma 2Carcinoma, Non-Small-Cell Lung 2Solid Tumors 1SCLC 1Rhabdomyosarcoma 1Retinal Neoplasms 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pleuropulmonary blastoma 1Peritoneal Neoplasms 1Neuroectodermal Tumors, Primitive, Peripheral 1Localized Extraskeletal Ewing Sarcoma 1Leukemia 1Eye Neoplasms 1Extensive Stage Small Cell Lung Cancer (ES-SCLC) 1Endometrial Neoplasms 1Carcinoma 1

Interventions

Vincristine 4Etoposide 4Carboplatin 4Topotecan 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Melphalan 1Eye Enucleation 1Drug Therapy 1Doxorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Retinoblastoma × Topotecan × Clear all
NCT00186888 2025-09-04

Study of Treatment for Patients With Cancer of the Eye -Retinoblastoma

St. Jude Children's Research Hospital

Phase 3 Completed
107 enrolled 34 charts
Other solid neoplasm

Eye Neoplasms, Retinoblastoma, Retinal Neoplasms

NCT04799002 2021-03-16

Topotecan and Melphalan for Retinoblastoma

Sun Yat-sen University

Phase 3 Recruiting
50 enrolled
Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡